- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Severe chronic plaque psoriasis
- Meeting Date: July 2020
- Public Summary Document (PSD) July 2020 PBAC Meeting - (PDF 771KB)
- Public Summary Document (PSD) July 2020 PBAC Meeting - (Word 41KB)
Guselkumab – July 2020
Guselkumab: Solution for injection 100 mg in 1 mL pen device; Tremfya®
Last updated
30 October 2020